THE RETURN (QUESTIONABLE) OF POSTMASTECTOMY RADIOTHERAPY

被引:31
作者
RECHT, A
机构
关键词
D O I
10.1200/JCO.1995.13.12.2861
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:2861 / 2864
页数:4
相关论文
共 65 条
[1]  
AHLBORN TN, 1988, SURG GYNECOL OBSTET, V166, P523
[2]   A PRELIMINARY ASSESSMENT OF FACTORS ASSOCIATED WITH RECURRENT DISEASE IN A SURGICAL ADJUVANT CLINICAL-TRIAL FOR PATIENTS WITH BREAST-CANCER WITH SPECIAL EMPHASIS ON THE AGGRESSIVENESS OF THERAPY [J].
AHMANN, DL ;
OFALLON, JR ;
SCANLON, PW ;
PAYNE, WS ;
BISEL, HF ;
EDMONSON, JH ;
FRYTAK, S ;
HAHN, RG ;
INGLE, JN ;
RUBIN, J ;
CREAGAN, ET .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1982, 5 (04) :371-381
[3]   ADEQUATE LOCOREGIONAL TREATMENT FOR EARLY BREAST-CANCER MAY PREVENT SECONDARY DISSEMINATION [J].
ARRIAGADA, R ;
RUTQVIST, LE ;
MATTSSON, A ;
KRAMAR, A ;
ROTSTEIN, S .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (12) :2869-2878
[4]   LOW-RISK BREAST-CANCER PATIENTS TREATED BY MASTECTOMY AND LOWER AXILLARY DISSECTION - THE PRESENT STATUS OF THE DANISH-BREAST-CANCER-COOPERATIVE-GROUP TRIAL 77-A [J].
AXELSSON, CK ;
BLICHERTTOFT, M .
ACTA ONCOLOGICA, 1988, 27 (6A) :605-609
[5]  
BIJKER N, 1994, EUR J SURG ONCOL, V20, P258
[6]   THE COMBINATION OF RADIOTHERAPY, ADJUVANT CHEMOTHERAPY (CYCLOPHOSPHAMIDE-DOXORUBICIN-FTORAFUR) AND TAMOXIFEN IN STAGE-II BREAST-CANCER - LONG-TERM FOLLOW-UP RESULTS OF A RANDOMIZED TRIAL [J].
BLOMQVIST, C ;
TIUSANEN, K ;
ELOMAA, I ;
RISSANEN, P ;
HIETANEN, T ;
HEINONEN, E ;
GROHN, P .
BRITISH JOURNAL OF CANCER, 1992, 66 (06) :1171-1176
[7]  
BUZDAR AU, 1990, CANCER, V65, P394, DOI 10.1002/1097-0142(19900201)65:3<394::AID-CNCR2820650303>3.0.CO
[8]  
2-2
[9]  
CASTIGLIONEGERT.M, 1994, ANN ONCOL, V5, P717
[10]   CAUSE-SPECIFIC MORTALITY IN LONG-TERM SURVIVORS OF BREAST-CANCER WHO PARTICIPATED IN TRIALS OF RADIOTHERAPY [J].
CUZICK, J ;
STEWART, H ;
RUTQVIST, L ;
HOUGHTON, J ;
EDWARDS, R ;
REDMOND, C ;
PETO, R ;
BAUM, M ;
FISHER, B ;
HOST, H ;
LYTHGOE, J ;
RIBEIRO, G ;
SCHEURLEN, H .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (03) :447-453